Commonwealth Equity Services
TXMD icon

Commonwealth Equity Services’s TherapeuticsMD TXMD Stock Holding History

Commonwealth Equity Services’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,281
Closed -$43K – 3803
2022
Q1 		$43K Buy
2,281
+737
+48% +$11.6K ﹤0.01% 3597
2021
Q4 		$27K Sell
1,544
-20
-1% -$599 ﹤0.01% 3583
2021
Q3 		$57K Sell
1,564
-550
-26% -$24.4K ﹤0.01% 3490
2021
Q2 		$125K Buy
2,114
+1,152
+120% +$69.8K ﹤0.01% 3370
2021
Q1 		$64K Sell
962
-186
-16% -$14.6K ﹤0.01% 3320
2020
Q4 		$69K Hold
1,148
– – ﹤0.01% 3110
2020
Q3 		$90K Sell
1,148
-8
-0.7% -$638 ﹤0.01% 2896
2020
Q2 		$72K Sell
1,156
-360
-24% -$21K ﹤0.01% 2811
2020
Q1 		$80K Buy
1,516
+772
+104% +$76.5K ﹤0.01% 2626
2019
Q4 		$90K Sell
744
-317
-30% -$45.6K ﹤0.01% 2754
2019
Q3 		$192K Buy
1,061
+680
+178% +$95.8K ﹤0.01% 2560
2019
Q2 		$49K Sell
381
-272
-42% -$48.8K ﹤0.01% 2697
2019
Q1 		$158K Buy
653
+1
+0.2% +$265 ﹤0.01% 2524
2018
Q4 		$124K Buy
652
+27
+4% +$6.59K ﹤0.01% 2451
2018
Q3 		$204K Buy
625
+154
+33% +$47.2K ﹤0.01% 2489
2018
Q2 		$147K Buy
471
+116
+33% +$35.4K ﹤0.01% 2540
2018
Q1 		$86K Hold
355
– – ﹤0.01% 2552
2017
Q4 		$107K Buy
+355
New +$98.8K ﹤0.01% 2503
2017
Q2 		– Sell
-269
Closed -$97K – 2559
2017
Q1 		$97K Hold
269
– – ﹤0.01% 2288
2016
Q4 		$78K Sell
269
-21
-7% -$6.51K ﹤0.01% 2218
2016
Q3 		$99K Sell
290
-52
-15% -$19K ﹤0.01% 2118
2016
Q2 		$145K Sell
342
-26
-7% -$10.7K ﹤0.01% 2037
2016
Q1 		$118K Buy
368
+131
+55% +$44.7K ﹤0.01% 2034
2015
Q4 		$123K Buy
+237
New +$87.5K ﹤0.01% 1998

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Commonwealth Equity Services's TXMD Position: Q2 2022 in Review

Commonwealth Equity Services sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 2,281 shares — an estimated $43K sold.

Commonwealth Equity Services first reported a position in TXMD in Q4 2015 and held it in 24 quarters. The position peaked at $204K in Q3 2018. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Commonwealth Equity Services reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 2,281 TherapeuticsMD shares in Q2 2022, an estimated $43K.
  • Commonwealth Equity Services first reported a position in TherapeuticsMD in Q4 2015 and held it in 24 quarters.
  • Commonwealth Equity Services's TherapeuticsMD position peaked at $204K in Q3 2018.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Commonwealth Equity Services's 13F filing for Q2 2022, filed 19 Jul 2022.